Procore stock price target raised to $90 from Goldman Sachs on stabilizing growth
Coca-Cola Europacific Partners plc (NASDAQ:CCEP) reported a series of share repurchases as part of its ongoing buyback program, according to a press release statement and a recent SEC filing.
On Monday, the company confirmed the purchase of 73,242 ordinary shares on US trading venues, including NASDAQ, and an additional 34,000 ordinary shares on London trading venues, which include the London Stock Exchange, CBOE Europe Limited (CXE and BXE), and Aquis. The highest price paid per share on US venues was $87.4450, while the lowest was $86.3200. On London venues, the highest price paid was £68.1000 and the lowest was £65.9000. The volume weighted average price was $86.7805 on US venues and ranged from £66.8006 to £66.8420 across London venues. All repurchased shares will be cancelled.
These transactions are part of the company’s share buyback program announced on February 14, 2025, under which Coca-Cola Europacific Partners expects to repurchase up to €1 billion of ordinary shares in aggregate.
The company also reported similar transactions for the previous week, with daily purchases on October 28, 29, 30, and 31, 2025. The aggregate number of shares bought each day ranged from approximately 71,500 to 73,800 on US venues, and from 33,700 to 34,000 on London venues. All shares acquired through these transactions are scheduled for cancellation.
Coca-Cola Europacific Partners is listed on Euronext Amsterdam, NASDAQ, the London Stock Exchange, and Spanish Stock Exchanges under the ticker CCEP. The information in this article is based on a press release statement and the company’s filing with the Securities and Exchange Commission.
In other recent news, UPS has completed its acquisition of Andlauer Healthcare Group for $1.6 billion. This all-cash transaction will enhance UPS Healthcare’s cold chain capabilities across North America and globally. Meanwhile, Coca-Cola Europacific Partners has been actively buying back shares in the US market, purchasing over 213,000 ordinary shares across several days, with no shares repurchased in the UK market. These buybacks are part of the company’s ongoing program, and all repurchased shares will be canceled.
Check-Cap has regained compliance with Nasdaq’s minimum bid price requirement and has postponed its Annual General Meeting following the announcement of a merger with MBody AI. This merger announcement led to a significant increase in Check-Cap’s share price and trading volumes. Kamada has scheduled its Annual General Meeting of Shareholders for December 10, 2025, providing relevant documents to shareholders in a recent SEC filing. These developments reflect strategic moves and corporate activities among these companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.